APG101 in Glioblastoma
NCT01071837
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
DRUG:
APG101
PROCEDURE:
Blood drawing
Sponsor
Apogenix GmbH